Techsomed Announces FDA Clearance for Ablation Treatment Planning and Confirmation Software

The cleared software is part of Techsomed’s BioTrace platform, an AI-Based Image-guided Ablation Therapy system. REHOVOT, Israel, Sept. 5, 2023 /PRNewswire/ — Techsomed Ltd., a medical software innovator dedicated to enhancing clinical impact in ablation therapy, announced today that it…

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks